Research use only.  Educational reference. Not medical advice. Not for human consumption.
⚙️ Mitochondrial Fatty-Acid Transporter

L-Carnitine (200 mg Vial) Dosage Protocol

L-Carnitine is an amino acid derivative essential for fatty acid transport into mitochondria for β-oxidation. Subcutaneous administration bypasses intestinal conversion to TMAO (linked to cardiovascular risk) and provides 100% bioavailability compared to 5–18% for oral dosing.

⚡ Quickstart Highlights

Vial contents
200 mg L-Carnitine
Final volume
2 mL
Concentration
100 mg/mL
One U-100 unit
1000 mcg in 0.01 mL

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (2.0 mL = 100 mg/mL)

WeekDaily DoseUnits (per injection) (mL)
Weeks 1–250 mg50 units (0.50 mL)
Weeks 3–8100 mg100 units (1.0 mL)
Weeks 9–12100 mg100 units (1.0 mL)

Frequency: Inject once daily subcutaneously. This 2.0 mL reconstitution provides optimal concentration for convenient dosing: 100 mg maintenance dose = exactly 1.0 mL (100 units). For advanced protocols requiring 150–200 mg daily, doses above 1.0 mL may be split into two injections at different sites to improve comfort.

Reconstitution Steps

  1. Draw 2.0 mL bacteriostatic water (0.9% benzyl alcohol) with a sterile syringe.
  2. Inject slowly down the vial wall to minimize foaming; avoid direct stream onto powder.
  3. Gently swirl or roll the vial until powder is fully dissolved (do not shake vigorously).
  4. Label vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Bacteriostatic water does not establish a universal use-by period; follow the exact product’s handling instructions.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on an 8–16 week daily protocol using 100 mg maintenance dose (most common). If starting with 50 mg titration (Weeks 1–2), subtract ~3–4 vials from totals below.

ItemQuantity
Peptide Vials (L-Carnitine, 200 mg each)8 weeks (56 days @ 100 mg/day) ≈ 28 vials
12 weeks (84 days @ 100 mg/day) ≈ 42 vials
16 weeks (112 days @ 100 mg/day) ≈ 56 vials
Insulin Syringes (U-100, 1 mL capacity)Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles)8 weeks (28 vials): 56 mL → 6 × 10 mL bottles
12 weeks (42 vials): 84 mL → 9 × 10 mL bottles
16 weeks (56 vials): 112 mL → 12 × 10 mL bottles
Alcohol SwabsPer week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100-count boxes
12 weeks: 168 swabs → recommend 2 × 100-count boxes
16 weeks: 224 swabs → recommend 3 × 100-count boxes

Each 200 mg vial prepared at 2.0 mL provides two 100 mg amounts or four 50 mg amounts.

Sharps Container: For safe disposal of used syringes and needles.

Storage Instructions

StateTemperatureDuration
Lyophilized−20°C (−4°F)Up to 24 months, dry & dark
Reconstituted2–8°C (35–46°F)Up to 28 days, protect from light

Important Notes

⚠ Research Use Only.

How This Works

L-Carnitine acts as an obligate cofactor for the carnitine palmitoyltransferase (CPT) enzyme system, which shuttles long-chain fatty acids across the inner mitochondrial membrane for β-oxidation and ATP production. Subcutaneous route bypasses gut bacterial conversion to trimethylamine-N-oxide (TMAO), the metabolite linked to elevated cardiovascular risk with oral dosing.

Potential Benefits & Side Effects

Potential Benefits

Side Effect Profile

Lifestyle Factors

Injection Technique

References

1
Sawicka AK et al. 'L-Carnitine supplementation systematic review' — J Int Soc Sports Nutr, 2020 View source ↗
2
Talenezhad N et al. 'L-Carnitine meta-analysis of 37 RCTs' — Clin Nutr ESPEN, 2020 View source ↗
3
Zhao Y et al. 'Subcutaneous L-carnitine bypasses TMAO production' — Mol Nutr Food Res, 2018 View source ↗